California Public Employees Retirement System Sells 21,184 Shares of IQVIA Holdings Inc. (NYSE:IQV)

California Public Employees Retirement System lessened its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 6.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 327,430 shares of the medical research company’s stock after selling 21,184 shares during the period. California Public Employees Retirement System’s holdings in IQVIA were worth $64,343,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Norges Bank purchased a new position in shares of IQVIA in the 4th quarter worth approximately $336,041,000. Raymond James Financial Inc. bought a new stake in IQVIA in the fourth quarter worth $236,120,000. American Century Companies Inc. boosted its stake in IQVIA by 396.0% during the fourth quarter. American Century Companies Inc. now owns 1,134,737 shares of the medical research company’s stock worth $222,987,000 after buying an additional 905,960 shares during the period. JPMorgan Chase & Co. increased its position in IQVIA by 46.2% during the third quarter. JPMorgan Chase & Co. now owns 1,845,711 shares of the medical research company’s stock valued at $437,378,000 after acquiring an additional 583,396 shares during the last quarter. Finally, Nordea Investment Management AB raised its stake in shares of IQVIA by 47.4% in the fourth quarter. Nordea Investment Management AB now owns 1,405,281 shares of the medical research company’s stock valued at $277,908,000 after acquiring an additional 452,029 shares during the period. Institutional investors own 89.62% of the company’s stock.

IQVIA Stock Down 2.9 %

IQVIA stock opened at $171.11 on Wednesday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.12. The firm has a market cap of $30.17 billion, a P/E ratio of 22.81, a P/E/G ratio of 1.99 and a beta of 1.50. The business has a fifty day moving average of $192.05 and a two-hundred day moving average of $205.13. IQVIA Holdings Inc. has a twelve month low of $169.37 and a twelve month high of $252.88.

IQVIA (NYSE:IQV) last issued its quarterly earnings data on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing analysts’ consensus estimates of $3.11 by ($0.21). IQVIA had a net margin of 8.91% and a return on equity of 28.81%. On average, analysts forecast that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

Analysts Set New Price Targets

IQV has been the subject of a number of recent analyst reports. Stephens initiated coverage on shares of IQVIA in a research note on Friday, December 20th. They set an “overweight” rating and a $250.00 price target for the company. BTIG Research cut IQVIA from a “buy” rating to a “neutral” rating in a research note on Monday, February 3rd. UBS Group dropped their price objective on IQVIA from $260.00 to $255.00 and set a “buy” rating for the company in a report on Friday, February 7th. Truist Financial reiterated a “buy” rating and issued a $263.00 target price (up previously from $261.00) on shares of IQVIA in a research note on Monday, February 10th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $270.00 target price on shares of IQVIA in a research note on Monday, February 10th. Five analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, IQVIA presently has a consensus rating of “Moderate Buy” and a consensus target price of $249.05.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.